Published in Transplant Proc on March 01, 1975
Long-term culture of B lymphocytes and their precursors from murine bone marrow. Proc Natl Acad Sci U S A (1982) 3.74
A selective culture system for generating terminal deoxynucleotidyl transferase-positive (TdT+) lymphoid precursor cells in vitro. I. Description of the culture system. J Exp Med (1984) 0.96
The effect of acute and prolonged administration of prednisolone and ACTH on lymphocyte subpopulations. Clin Exp Immunol (1977) 0.89
Rat eosinophil-mediated antibody-dependent cellular cytotoxicity: investigations of the mechanisms of target cell lysis and inhibition by glucocorticoids. Clin Exp Immunol (1982) 0.82
Influence of corticosteroid therapy on the serum antibody response to influenza vaccine in elderly patients with chronic pulmonary diseases. EXCLI J (2013) 0.77
Effect of hydrocortisone on interleukin-6 production in human ,peripheral blood rnononuclear ceils. Mediators Inflamm (1992) 0.75
Renal transplant rejection after gradual withdrawal of prednisolone. Br Med J (1980) 0.75
The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature (1986) 14.56
A method for isolation of intact, translationally active ribonucleic acid. DNA (1983) 13.67
bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell (1991) 8.27
Nucleotide sequence and amplification in bacteria of structural gene for rat growth hormone. Nature (1977) 7.97
Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature (1990) 5.63
Structure and specificity of nuclear receptor-coactivator interactions. Genes Dev (1998) 5.28
Mouse myelomas and lymphomas in culture. Exp Cell Res (1970) 5.12
Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc Natl Acad Sci U S A (1991) 4.72
Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J (1995) 4.68
A structural role for hormone in the thyroid hormone receptor. Nature (1995) 4.27
DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell (1994) 4.22
The c-myc oncogene perturbs B lymphocyte development in E-mu-myc transgenic mice. Cell (1986) 3.72
Human growth hormone: complementary DNA cloning and expression in bacteria. Science (1979) 3.67
Characterization of human prorenin expressed in mammalian cells from cloned cDNA. Proc Natl Acad Sci U S A (1986) 3.60
CLINICAL STUDIES OF THE BLOOD VOLUME. V. HYPERTHYROIDISM AND MYXEDEMA. J Clin Invest (1939) 3.46
Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival. Proc Natl Acad Sci U S A (1999) 3.45
Construction and analysis of recombinant DNA for human chorionic somatomammotropin. Nature (1977) 3.13
Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell (1993) 3.09
Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. EMBO J (1994) 2.91
A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes. EMBO J (1998) 2.82
Primary structure and evolution of rat growth hormone gene. Proc Natl Acad Sci U S A (1981) 2.80
Activation of a heterologous promoter in response to dexamethasone and cadmium by metallothionein gene 5'-flanking DNA. Cell (1984) 2.78
Negative regulation by glucocorticoids through interference with a cAMP responsive enhancer. Science (1988) 2.78
Glucocorticoid receptors: relations between steroid binding and biological effects. J Mol Biol (1972) 2.70
Expression of the immunoglobulin C mu gene in mouse T and B lymphoid and myeloid cell lines. Proc Natl Acad Sci U S A (1980) 2.57
Regulation of growth hormone messenger RNA by thyroid and glucocorticoid hormones. Proc Natl Acad Sci U S A (1977) 2.47
Use of genotypic resistance testing to guide hiv therapy: clinical impact and cost-effectiveness. Ann Intern Med (2001) 2.47
CLINICAL STUDIES OF THE BLOOD VOLUME. VIII. MACROCYTIC AND HYPOCHROMIC ANEMIAS DUE TO CHRONIC BLOOD LOSS, HEMOLYSIS AND MISCELLANEOUS CAUSES, AND POLYCYTHEMIA VERA. J Clin Invest (1939) 2.45
Structure of cloned DNA complementary to rat prolactin messenger RNA. J Biol Chem (1980) 2.44
Specific cytoplasmic glucocorticoid hormone receptors in hepatoma tissue culture cells. Proc Natl Acad Sci U S A (1971) 2.35
Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors. Science (1998) 2.31
Interferon-gamma induces enhanced expression of Ia and H-2 antigens on B lymphoid, macrophage, and myeloid cell lines. J Immunol (1983) 2.30
The thyroid hormone receptor-beta-selective agonist GC-1 differentially affects plasma lipids and cardiac activity. Endocrinology (2000) 2.26
bmi-1 transgene induces lymphomas and collaborates with myc in tumorigenesis. Oncogene (1993) 2.25
Human prolactin. cDNA structural analysis and evolutionary comparisons. J Biol Chem (1981) 2.19
Further evidence for posttranscriptional control of inducible tyrosine aminotransferase synthesis in cultured hepatoma cells. Nat New Biol (1972) 2.15
Cell-mediated immune response in vitro. II. The role of thymus and thymus-derived lymphocytes. Cell Immunol (1972) 2.15
Differentiated functions expressed by cultured mouse lymphoma cells. II. Theta antigen, surface immunoglobulin and a receptor for antibody on cells of a thymoma cell line. J Immunol (1973) 2.14
Tissue effects of glucocorticoids. Am J Med (1972) 2.11
Promoter elements of vav drive transgene expression in vivo throughout the hematopoietic compartment. Blood (1999) 2.06
One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group. Gut (1997) 2.00
Role of DNA and specific cytoplasmic receptors in glucocorticoid action. Proc Natl Acad Sci U S A (1972) 1.97
Structural analysis of the prolactin gene suggests a separate origin for its 5' end. Nature (1982) 1.94
Transcripts of the immunoglobulin C mu gene vary in structure and splicing during lymphoid development. Proc Natl Acad Sci U S A (1980) 1.89
Mutations in the p53 and SCID genes cooperate in tumorigenesis. Genes Dev (1996) 1.89
Bcl-2 expression promotes B- but not T-lymphoid development in scid mice. Nature (1994) 1.88
Molecular cloning of DNA complementary to bovine growth hormone mRNA. J Biol Chem (1980) 1.86
Abnormalities of the immune system induced by dysregulated bcl-2 expression in transgenic mice. Curr Top Microbiol Immunol (1990) 1.86
Genes for growth hormone, chorionic somatommammotropin, and growth hormones-like gene on chromosome 17 in humans. Science (1980) 1.85
Acute epiglottitis in children. Laryngoscope (1967) 1.83
Nucleotide sequence of part of the gene for human chorionic somatomammotropin: purification of DNA complementary to predominant mRNA species. Cell (1977) 1.81
Glucocorticoid receptor binding and activation of a heterologous promoter by dexamethasone by the first intron of the human growth hormone gene. Mol Cell Biol (1985) 1.78
Transcriptional activators differ in their responses to overexpression of TATA-box-binding protein. Mol Cell Biol (1995) 1.77
Effect of cloned interferon-gamma on expression of H-2 and Ia antigens on cell lines of hemopoietic, lymphoid, epithelial, fibroblastic and neuronal origin. Eur J Immunol (1984) 1.73
Structure of genes for human growth hormone and chorionic somatomammotropin. Proc Natl Acad Sci U S A (1979) 1.71
Transcriptional regulation of vav, a gene expressed throughout the hematopoietic compartment. Blood (1998) 1.70
The relationship between glucocorticoid binding and tyrosine aminotransferase induction in hepatoma tissue culture cells. Proc Natl Acad Sci U S A (1970) 1.67
N-myc transgene promotes B lymphoid proliferation, elicits lymphomas and reveals cross-regulation with c-myc. EMBO J (1989) 1.65
Analysis by immunocytochemistry and in situ hybridization of renin and its mRNA in kidney, testis, adrenal, and pituitary of the rat. Proc Natl Acad Sci U S A (1986) 1.62
Growth hormone gene transcription is regulated by thyroid and glucocorticoid hormones in cultured rat pituitary tumor cells. J Biol Chem (1982) 1.62
Expression of cloned beta-endorphin gene sequences by Escherichia coli. Nature (1980) 1.59
Mechanism of resistance to steroids: glucocorticoid receptor defect in lymphoma cells. Nat New Biol (1972) 1.58
Subunit structure of cell surface proteins: disulfide bonding in antigen receptors, Ly-2/3 antigens, and transferrin receptors of murine T and B lymphocytes. Proc Natl Acad Sci U S A (1981) 1.58
Glucocorticoid receptors in lymphoma cells in culture: relationship to glucocorticoid killing activity. Science (1971) 1.56
A high-affinity subtype-selective agonist ligand for the thyroid hormone receptor. Chem Biol (1998) 1.55
Acute syphilitic meningitis in a man with seropositivity for human immunodeficiency virus infection and normal numbers of CD4 T lymphocytes. Arch Intern Med (1992) 1.55
Identification of a tumor necrosis factor-responsive element in the tumor necrosis factor alpha gene. J Biol Chem (1991) 1.52
Hypercalcemia of thyrotoxicosis. Ann Intern Med (1966) 1.52
E mu-bcl-2 transgene facilitates spontaneous transformation of early pre-B and immunoglobulin-secreting cells but not T cells. Oncogene (1993) 1.51
Corticotropin and beta-endorphin: construction and analysis of recombinant DNA complementary to mRNA for the common precursor. Proc Natl Acad Sci U S A (1979) 1.49
The nuclear receptor corepressor (N-CoR) contains three isoleucine motifs (I/LXXII) that serve as receptor interaction domains (IDs). Mol Endocrinol (2000) 1.46
Human trabecular cells. I. Establishment in tissue culture and growth characteristics. Invest Ophthalmol Vis Sci (1979) 1.43
Mutations in bacteriophage lambda affecting particle morphogenesis. Virology (1968) 1.42
Thyroid hormone receptors. Binding characteristics and lack of hormonal dependency for nuclear localization. J Biol Chem (1975) 1.42
Enforced Bcl-2 expression inhibits antigen-mediated clonal elimination of peripheral B cells in an antigen dose-dependent manner and promotes receptor editing in autoreactive, immature B cells. J Exp Med (1997) 1.41
Immunoglobulin of T lymphoma cells. Biosynthesis, surface representation, and partial characterization. Biochemistry (1975) 1.39
FADD/MORT1 regulates the pre-TCR checkpoint and can function as a tumour suppressor. EMBO J (2000) 1.38
An investigation of the efficiency of the oral airway and a technique for improving the airway in the early post-operative period following mandibular osteotomy. Br J Oral Surg (1970) 1.36
Insights from Bcl-2 and Myc: malignancy involves abrogation of apoptosis as well as sustained proliferation. Cancer Res (1999) 1.35
Regulation of growth hormone gene expression: synergistic effects of thyroid and glucocorticoid hormones. Proc Natl Acad Sci U S A (1977) 1.35
Hormone receptors. N Engl J Med (1979) 1.34
Solubilized nuclear "receptors" for thyroid hormones. Physical characteristics and binding properties, evidence for multiple forms. J Biol Chem (1976) 1.34
Differential expression of the invariant chain in mouse tumor cells: relationship to B lymphoid development. J Immunol (1984) 1.33
An E mu-v-abl transgene elicits plasmacytomas in concert with an activated myc gene. EMBO J (1990) 1.32
Positive and negative selection of T cells in T-cell receptor transgenic mice expressing a bcl-2 transgene. Proc Natl Acad Sci U S A (1994) 1.32
Regulation of thyroid hormone receptor isoforms in physiological and pathological cardiac hypertrophy. Circ Res (2001) 1.30
Steroid-induced nuclear binding of glucocorticoid receptors in intact hepatoma cells. J Mol Biol (1973) 1.29
Absence of p53 allows direct immortalization of hematopoietic cells by the myc and raf oncogenes. Cell (1995) 1.28
Estradiol repression of tumor necrosis factor-alpha transcription requires estrogen receptor activation function-2 and is enhanced by coactivators. Proc Natl Acad Sci U S A (1999) 1.26
Extra-atrial expression of the gene for atrial natriuretic factor. Proc Natl Acad Sci U S A (1986) 1.25
Transgenic models of lymphoid neoplasia and development of a pan-hematopoietic vector. Oncogene (1999) 1.24
Production of RNA for secreted immunoglobulin mu chains does not require transcriptional termination 5' to the microM exons. Nature (1983) 1.24
The nuclear hormone receptor gene superfamily. Annu Rev Med (1995) 1.23
Lymphomas in E mu-Pim1 transgenic mice exposed to pulsed 900 MHZ electromagnetic fields. Radiat Res (1997) 1.23
Progenitor tumours from Emu-bcl-2-myc transgenic mice have lymphomyeloid differentiation potential and reveal developmental differences in cell survival. EMBO J (1996) 1.22
Epidermal growth factor and expression of specific genes: effects on cultured rat pituitary cells are dissociable from the mitogenic response. Proc Natl Acad Sci U S A (1980) 1.21
A filter assay for steroid hormone receptors. Biochemistry (1973) 1.21
The immunoglobulin mu constant region gene is expressed in mouse thymocytes. Nature (1980) 1.19
Thyroid hormone receptors and responses. Recent Prog Horm Res (1979) 1.19